Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1087057109335671v1
14/6/596    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Haynes, M. K.
Right arrow Articles by Thompson, T. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haynes, M. K.
Right arrow Articles by Thompson, T. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Detection of Intracellular Granularity Induction in Prostate Cancer Cell Lines by Small Molecules Using the HyperCyt® High-Throughput Flow Cytometry System

Mark K. Haynes

University of New Mexico Center for Molecular Discovery, Albuquerque, New Mexico, University of New Mexico Cancer Center, Albuquerque, New Mexico, MHaynes{at}salud.unm.edu

J. Jacob Strouse

University of New Mexico Center for Molecular Discovery, Albuquerque, New Mexico, University of New Mexico Cancer Center, Albuquerque, New Mexico

Anna Waller

University of New Mexico Center for Molecular Discovery, Albuquerque, New Mexico, University of New Mexico Cancer Center, Albuquerque, New Mexico

Andrei Leitao

University of New Mexico Center for Molecular Discovery, Albuquerque, New Mexico, Division of Biocomputing, Department of Biochemistry and Molecular Biology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico

Ramona F. Curpan

University of New Mexico Center for Molecular Discovery, Albuquerque, New Mexico, Division of Biocomputing, Department of Biochemistry and Molecular Biology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico

Cristian Bologa

University of New Mexico Center for Molecular Discovery, Albuquerque, New Mexico, Division of Biocomputing, Department of Biochemistry and Molecular Biology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico

Tudor I. Oprea

University of New Mexico Center for Molecular Discovery, Albuquerque, New Mexico, Division of Biocomputing, Department of Biochemistry and Molecular Biology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico

Eric R. Prossnitz

University of New Mexico Center for Molecular Discovery, Albuquerque, New Mexico, University of New Mexico Cancer Center, Albuquerque, New Mexico, Department of Cellular Biology and Physiology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico

Bruce S. Edwards

University of New Mexico Center for Molecular Discovery, Albuquerque, New Mexico, University of New Mexico Cancer Center, Albuquerque, New Mexico, Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico

Larry A. Sklar

University of New Mexico Center for Molecular Discovery, Albuquerque, New Mexico, University of New Mexico Cancer Center, Albuquerque, New Mexico, Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico

Todd A. Thompson

College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, New Mexico

Prostate cancer is a leading cause of death among men due to the limited number of treatment strategies available for advanced disease. Discovery of effective chemotherapeutics involves the identification of agents that inhibit cancer cell growth. Increases in intracellular granularity have been observed during physiological processes that include senescence, apoptosis, and autophagy, making this phenotypic change a useful marker for identifying small molecules that induce cellular growth arrest or death. In this regard, epithelial-derived cancer cell lines appear uniquely susceptible to increased intracellular granularity following exposure to chemotherapeutics. We have established a novel flow cytometry approach that detects increases in side light scatter in response to morphological changes associated with intracellular granularity in the androgen-sensitive LNCaP and androgen-independent PC3 human prostate cancer cell lines. A cell-based assay was developed to screen for small molecule inducers of intracellular granularity using the HyperCyt® high-throughput flow cytometry platform. Validation was performed using the Prestwick Chemical Library, where known modulators of LNCaP intracellular granularity, such as testosterone, were identified. Nonandrogenic inducers of granularity were also detected. A further screen of ~25,000 small molecules led to the identification of a class of aryl-oxazoles that increased intracellular granularity in both cell lines, often leading to cell death. The most potent agents exhibited submicromolar efficacy in LNCaP and PC3 cells. (Journal of Biomolecular Screening. 2009:596-609)

Key Words: HyperCyt® high-throughput flow cytometry • small molecule screening • intracellular granularity • prostate cancer

This version was published on July 1, 2009

Journal of Biomolecular Screening, Vol. 14, No. 6, 596-609 (2009)
DOI: 10.1177/1087057109335671


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?